✦ LIBER ✦

A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease

✍ Scribed by Liana DesHarnais Castel; Kamila Bajwa; Justin P. Markle; Justin W. Timbie; Christopher Zacker; Kevin A. Schulman

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 37 KB
Volume: 9
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s005200100249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of oral ibandronate c

Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy

✍ E. Cock; J. Hutton; P. Canney; J. J. Body; P. Barrett-Lee; M. P. Neary; G. Lewis 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

The impact of zoledronic acid therapy in

The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis

✍ Kostantinos Zarogoulidis; Eufimia Boutsikou; Pavlos Zarogoulidis; Ellada Elefthe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 213 KB 👁 2 views

## Abstract Bone metastases occur in 20–40% of patients with lung cancer. Recent studies demonstrate a direct antiproliferative effect of 3rd generation bisphosphonates (BPs) on lung tumors, which may influence the survival. Therefore, we examined the clinical impact of zoledronic acid (ZOL; Zometa

A Phase I, open label, dose ranging tria

A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease

✍ James R. Berenson; Robert Vescio; Kathryn Henick; Carol Nishikubo; Matthew Retti 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Scintigraphic, biochemical, and clinical

Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget’s disease of bone

✍ Avraam Avramidis; Stergios A. Polyzos; Efstratios Moralidis; Georgios Arsos; Zoe 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 280 KB

Serum homocysteine, folate and vitamin B

Serum homocysteine, folate and vitamin B12in patients with Paget’s disease of bone: the effect of zoledronic acid

✍ Stergios A. Polyzos; Athanasios D. Anastasilakis; Zoe Efstathiadou; Ioannis Lits 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 171 KB

Zoledronic acid is superior to pamidrona

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

✍ Lee S. Rosen; David H. Gordon; William Dugan Jr.; Pierre Major; Peter D. Eisenbe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## BACKGROUND Treatment with zoledronic acid (Zol) was compared with a dose of 90 mg of pamidronate (Pam) in breast carcinoma (BC) patients with at least 1 osteolytic lesion based on data from a Phase III, randomized trial. ## METHODS Overall, 1130 patients with breast carcinoma who